Workflow
康辰药业: 康辰药业2024年年度股东大会决议公告
603590Konruns(603590) 证券之星·2025-05-16 11:42

Meeting Overview - The shareholders' meeting of Beijing Kangchen Pharmaceutical Co., Ltd. was held on May 16, 2025, at the company's conference room in Changping District, Beijing [1] - The meeting was attended by shareholders representing 47.0795% of the total shares [1] Voting Results - All non-cumulative voting proposals were approved with significant support, including: - Proposal 1: 99.5307% approval from A-shareholders [1] - Proposal 2: 99.5969% approval from A-shareholders [1] - Proposal 3: 99.5973% approval from A-shareholders [1] - Proposal 4: 99.5987% approval from A-shareholders [1] - Proposal 5: 99.5836% approval from A-shareholders [1] - The voting process was conducted in accordance with the Company Law and the company's articles of association [1][2] Legal Compliance - The meeting was legally compliant, with the presence of lawyers Liu Siliang and Zhong Ruxue confirming the legality of the meeting's procedures and voting results [2]